FTL001
/ Sound Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 10, 2024
Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of FTL001
(clinicaltrials.gov)
- P1 | N=44 | Recruiting | Sponsor: Sound Biopharmaceuticals Ltd.
Metastases • New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1